We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Patrick Industries
PATK
$2.9B
| $1.96M | ﹤0.01% |
99,341
+16,235
| +20% | +$460K |
|
1652
Marcus & Millichap
MMI
$1.18B
| $1.96M | ﹤0.01% |
57,074
+40,168
| +238% | +$1.38M |
|
|
HT
1653
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.96M | ﹤0.01% |
111,704
+19,688
| +21% | +$368K |
|
1654
Tootsie Roll Industries
TR
$2.99B
| $1.96M | ﹤0.01% |
74,210
+27,650
| +59% | +$706K |
|
1655
Atara Biotherapeutics
ATRA
$76.9M
| $1.96M | ﹤0.01% |
2,252
+762
| +51% | +$708K |
|
1656
Mueller Water Products
MWA
$4.13B
| $1.96M | ﹤0.01% |
214,953
+68,964
| +47% | +$723K |
|
|
DLPH
1657
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $1.95M | ﹤0.01% |
136,237
+53,050
| +64% | +$1.03M |
|
1658
Hilltop Holdings
HTH
$2.28B
| $1.95M | ﹤0.01% |
109,315
+30,746
| +39% | +$583K |
|
|
ACOR
1659
DELISTED
Acorda Therapeutics
ACOR
| $1.95M | ﹤0.01% |
1,042
+181
| +21% | +$394K |
|
|
KRA
1660
DELISTED
Kraton Corporation
KRA
| $1.95M | ﹤0.01% |
89,131
+15,221
| +21% | +$446K |
|
|
BRSP
1661
BrightSpire Capital
BRSP
$633M
| $1.95M | ﹤0.01% |
123,247
+43,737
| +55% | +$832K |
|
|
TDAY
1662
USA Today Co
TDAY
$1.27B
| $1.94M | ﹤0.01% |
167,617
+30,097
| +22% | +$420K |
|
1663
Photronics
PLAB
$1.89B
| $1.93M | ﹤0.01% |
199,525
+31,848
| +19% | +$306K |
|
1664
Ironwood Pharmaceuticals
IRWD
$683M
| $1.93M | ﹤0.01% |
222,443
+73,244
| +49% | +$841K |
|
1665
Shutterstock
SSTK
$229M
| $1.93M | ﹤0.01% |
53,522
+8,545
| +19% | +$349K |
|
1666
Addus HomeCare
ADUS
$2.17B
| $1.93M | ﹤0.01% |
28,365
+20,107
| +243% | +$1.37M |
|
|
RTEC
1667
DELISTED
Rudolph Technologies Inc
RTEC
| $1.92M | ﹤0.01% |
93,849
+15,912
| +20% | +$323K |
|
|
HTLF
1668
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.92M | ﹤0.01% |
43,688
+12,507
| +40% | +$655K |
|
|
TLRD
1669
DELISTED
Tailored Brands, Inc.
TLRD
| $1.92M | ﹤0.01% |
140,795
+24,808
| +21% | +$511K |
|
|
TRST
1670
Trustco Bank Corp NY
TRST
$968M
| $1.92M | ﹤0.01% |
55,938
+9,430
| +20% | +$357K |
|
1671
Nelnet
NNI
$4.89B
| $1.92M | ﹤0.01% |
36,581
+8,168
| +29% | +$440K |
|
|
GHDX
1672
DELISTED
Genomic Health, Inc.
GHDX
| $1.91M | ﹤0.01% |
29,707
+7,974
| +37% | +$559K |
|
|
NAV
1673
DELISTED
Navistar International
NAV
| $1.9M | ﹤0.01% |
73,311
+21,009
| +40% | +$657K |
|
|
WLL
1674
DELISTED
Whiting Petroleum Corporation
WLL
| $1.9M | ﹤0.01% |
1,114
-20
| -2% | -$51.4K |
|
|
SCS
1675
DELISTED
Steelcase
SCS
| $1.89M | ﹤0.01% |
127,719
+36,778
| +40% | +$598K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.